Acknowledgements
We are grateful for Celgene for funding the study and providing Lenalidomide free of charge, Cancer Research UK & UCL Cancer Trials Centre for overseeing the study and all staff & patients who participated.
Potential conflict of interest
Disclosure forms provided by the authors are available with the full text of this article online at https://doi.org/10.1080/10428194.2017.1399311.